Company news
Valbiotis Sa (EURONEXT:ALVAL) news
Every Valbiotis Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition f...
July 22, 2026
VALBIOTIS SA: Valbiotis announces the success of its capital increase of €10.2M
June 26, 2026
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained PSR in the amount of €10.2M secured by commitments amo...
June 8, 2026
VALBIOTIS SA: Valbiotis continues its expansion in Asia
May 11, 2026
VALBIOTIS SA: Valbiotis expands its e-commerce to Belgium and Luxembourg
April 23, 2026
VALBIOTIS SA: General Meeting of April 17, 2026: All Resolutions Approved
April 17, 2026
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
March 19, 2026
VALBIOTIS SA: 2025 Financial Results
March 2, 2026
VALBIOTIS SA: Valbiotis expands its ValbiotisPLUS® range with the new Menopause & Perimenopause solution
February 2, 2026
VALBIOTIS SA: 2025 Commercial roll-out underway, reflected in a strong ramp-up in revenues in Q4
January 27, 2026
VALBIOTIS SA: Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS®...
January 26, 2026
VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver ...
January 12, 2026
VALBIOTIS SA: Valbiotis announces an exclusive distribution agreement in the Middle East
January 8, 2026
VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance
December 18, 2025
VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic li...
December 8, 2025
VALBIOTIS SA: Valbiotis announces a major strategic agreement in Asia
November 17, 2025
VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap
October 9, 2025